The Onset Time of Rocuronium in Emergency and Elective Surgery

• Status: Unknown status
• Trial end date: 2016-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Rocuronium, a nondepolarizing neuromuscular blocking agent, is used in general anesthesia to provide conditions for endotracheal intubating. Recommended dose is 0,6 mg/kg and 90 seconds after intravenous injection, patients can be intubated.

Anxiety levels may vary in patients undergoing emergency and elective surgery. Patients undergoing emergency surgery may display exaggerated laryngoscopic responses. The purpose of this study is to investigate the effect of patient anxiety levels on the onset time of rocuronium in terms of anxiety scores and train of four (TOF) 0.1 times.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Diskapi Yildirim Beyazit Education and Research Hospital
• Treatments: Fentanyl; Propofol; Rocuronium

Criteria

Inclusion Criteria:

• BMI 18,5-24,9

• ASA 1

Exclusion Criteria:

• Allergy to used drugs during anesthesia

• Neuromuscular disease

• Liver and kidney failure

• Heart failure

• Anticipated difficult airway

• Using aminoglycosides

• BMI<18,5 and BMI>25